부산대학교 도서관

Mahomedradja RF; Department of Hospital Pharmacy, Division of Clinical Pharmacology, Department of Hospital Pharmacy, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.; Department of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Bognàr T; Department of Clinical Pharmacy, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; van Schie KE; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Kuipers IT; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; de Witte MA; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Kuball JHE; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Nur E; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.; Wilhelm BJ; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Heerma van Voss MR; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Franken L; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Lalmohamed A; Department of Clinical Pharmacy, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Swart ENL; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; de Leeuw DC; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Bartelink IH; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Bognàr T; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands. Electronic address: t.bognar-2@umcutrecht.nl.; Bartelink IH; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands.; van der Elst KCM; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Kingma JS; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.; Smeijsters EH; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Lindemans CA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Pediatrics, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Egberts ACG; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Kuball JHE; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; de Witte MA; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; de Vries Schultink AHM; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Lalmohamed A; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Zheng S; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.; Rümke LLW; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.; Tello Rubio B; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.; Rogers MRC; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.; van Sluis GL; Department of Haematology UMC Utrecht, Utrecht, The Netherlands.; Kuball JHE; Department of Haematology UMC Utrecht, Utrecht, The Netherlands.; Riezebos-Brilman A; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.; Lebbink RJ; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.; Verduyn Lunel FM; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.

Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Solves P; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Lozano M; University Clínic Hospital, Barcelona, Spain.; Zhiburt E; Anguita Velasco J; Maria Pérez-Corral A; Monsalvo-Saornil S; Yamazaki S; Okazaki H; Selleng K; Aurich K; Krüger W; Buser A; Holbro A; Infanti L; Stehle G; Pierelli L; Matteocci A; Rigacci L; De Vooght KMK; Kuball JHE; Fielding KL; Westerman DA; Wood EM; Cohn CS; Johnson A; Koh MBC; Qadir D; Cserti-Gazdewich C; Daguindau E; Angelot-Delettre F; Tiberghien P; Wendel-Neto S; Fachini RM; Morton S; Craddock C; Lumley M; Antoniewicz-Papis J; Hałaburda K; Łętowska M; Dunbar N; Dartmouth-Hitchcock Medical Center - Pathology, Lebanon, NH, USA.

Publisher: Blackwell Science Country of Publication: England NLM ID: 0413606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0410 (Electronic) Linking ISSN: 00429007 NLM ISO Abbreviation: Vox Sang Subsets: MEDLINE; PubMed not MEDLINE

Solves P; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Lozano M; University Clínic Hospital, Barcelona, Spain.; Zhiburt E; Pirogov National Medical Surgical Center, Moscow, Russia.; Anguita Velasco J; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Maria Pérez-Corral A; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Madrid, Spain.; Monsalvo-Saornil S; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Yamazaki S; University of Tokyo Hospital, Tokyo, Japan.; Okazaki H; University of Tokyo Hospital, Tokyo, Japan.; Selleng K; Institut für Immunologie und Transfusionsmedizin, Greifswald, Germany.; Aurich K; Institut für Immunologie und Transfusionsmedizin, Greifswald, Germany.; Krüger W; Klinik für Hämatologie und Onkologie, Universitätsmedizin Greifswald, Greifswald, Germany.; Buser A; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.; Holbro A; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.; Infanti L; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.; Stehle G; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland.; Pierelli L; Sapienza University, Rome, Italy.; San Camillo Forlanini Hospital, Rome, Italy.; Matteocci A; San Camillo Forlanini Hospital, Rome, Italy.; Rigacci L; San Camillo Forlanini Hospital, Rome, Italy.; De Vooght KMK; University Medical Center Utrecht, Utrecht, the Netherlands.; Kuball JHE; University Medical Center Utrecht, Utrecht, the Netherlands.; Fielding KL; Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Vic, Australia.; Westerman DA; Peter MacCallum Cancer Centre, Parkville, Vic, Australia.; Wood EM; Peter MacCallum Cancer Centre, Parkville, Vic, Australia.; Cohn CS; University of Minnesota, Minneapolis, MN, USA.; Johnson A; University of Minnesota, Minneapolis, MN, USA.; Koh MBC; St George's University Hospital, London, UK.; Qadir D; St George's University Hospital, London, UK.; Cserti-Gazdewich C; University Health Network/University of Toronto, Toronto, ON, Canada.; Daguindau E; University Hospital of Besancon, Besançon, France.; Angelot-Delettre F; Etablissement Français du Sang Bourgogne Franche-Comté, Besançon, France.; Tiberghien P; Etablissement Français du Sang, La Plaine St-Denis, France.; Wendel-Neto S; Sírio-Libanês Blood Bank, São Paulo, Brazil.; Fachini RM; Sírio-Libanês Blood Bank, São Paulo, Brazil.; Morton S; NHS Blood and Transplant, Birmingham, UK.; Craddock C; University Hospitals Birmingham NHS Foundation Trust, Sutton Coldfield, UK.; Lumley M; University Hospitals Birmingham NHS Foundation Trust, Sutton Coldfield, UK.; Antoniewicz-Papis J; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Hałaburda K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Łętowska M; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Dunbar N; Dartmouth-Hitchcock Medical Center - Pathology, Lebanon, NH, USA.

Publisher: Blackwell Science Country of Publication: England NLM ID: 0413606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0410 (Electronic) Linking ISSN: 00429007 NLM ISO Abbreviation: Vox Sang Subsets: MEDLINE; PubMed not MEDLINE

Eberhard JM; 1. Department of Medicine, Infectious Diseases Unit, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.; DZIF Partner Site (German Center for Infection Research), Hamburg-Lübeck-Borstel-Riems Site, Hamburg, Germany.; Angin M; Institut Pasteur, HIV, Inflammation and Persistence, 75015 Paris, France.; Passaes C; Institut Pasteur, HIV, Inflammation and Persistence, 75015 Paris, France.; Salgado M; AIDS Research Institute IrsiCaixa, 08916 Badalona, Spain.; Monceaux V; Institut Pasteur, HIV, Inflammation and Persistence, 75015 Paris, France.; Knops E; Institute of Virology, University of Cologne, 50935 Cologne, Germany.; Kobbe G; Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.; Jensen B; Department of Gastroenterology, Hepatology, and Infectious Diseases, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.; Christopeit M; Department of Stem Cell Transplantation, University Medical Center HamburgEppendorf, 20246 Hamburg, Germany.; Kröger N; Department of Stem Cell Transplantation, University Medical Center HamburgEppendorf, 20246 Hamburg, Germany.; Vandekerckhove L; HIV Cure Research Center, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, B-9000 Ghent, Belgium.; Badiola J; Hematology Department, Virgen de las Nieves University Hospital, 18014 Granada, Spain.; Bandera A; San Gerardo Hospital, University of Milano-Bicocca, 20900 Monza, Italy.; Raj K; Department of Haematology, King's College Hospital, London SE5 9RS, UK.; van Lunzen J; 1. Department of Medicine, Infectious Diseases Unit, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.; ViiV Healthcare, Brentford, Middlesex TW8 9GS, UK.; Hütter G; Cellex, 01307 Dresden, Germany.; Kuball JHE; University Medical Center Utrecht, 3584 CX, Utrecht, Netherlands.; Martinez-Laperche C; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitarias Gregorio Marañón, Universidad Complutense, 28007 Madrid, Spain.; Balsalobre P; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitarias Gregorio Marañón, Universidad Complutense, 28007 Madrid, Spain.; Kwon M; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitarias Gregorio Marañón, Universidad Complutense, 28007 Madrid, Spain.; Díez-Martín JL; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitarias Gregorio Marañón, Universidad Complutense, 28007 Madrid, Spain.; Nijhuis M; University Medical Center Utrecht, 3584 CX, Utrecht, Netherlands.; Wensing A; University Medical Center Utrecht, 3584 CX, Utrecht, Netherlands.; Martinez-Picado J; AIDS Research Institute IrsiCaixa, 08916 Badalona, Spain.; UVic-UCC, 08500 Vic, Spain.; ICREA, 08010 Barcelona, Spain.; Schulze Zur Wiesch J; 1. Department of Medicine, Infectious Diseases Unit, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany. asier.saez-cirion@pasteur.fr julianszw@gmail.com.; DZIF Partner Site (German Center for Infection Research), Hamburg-Lübeck-Borstel-Riems Site, Hamburg, Germany.; Sáez-Cirión A; Institut Pasteur, HIV, Inflammation and Persistence, 75015 Paris, France. asier.saez-cirion@pasteur.fr julianszw@gmail.com.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Huyveneers LEP; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Bruns A; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Department of Hematology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Stam A; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Ellerbroek P; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; de Jong D; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Nagy NA; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Gumbs SBH; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Tesselaar K; Central Laboratory of Translational Immunology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Bosman K; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Salgado M; IrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Hütter G; DKMS CC, 72072 Tübingen, Germany.; Brosens LAA; Department of Pathology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Kwon M; Department of Hematology, Hospital General Universitario Gregorio Maranon, 28007 Madrid, Spain.; Diez Martin J; Department of Hematology, Hospital General Universitario Gregorio Maranon, 28007 Madrid, Spain.; van der Meer JTM; Department of Internal Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.; de Kort TM; Department of Anatomy and Embryology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Sáez-Cirión A; HIV Inflammation and Persistence, Institut Pasteur, Université Paris Cité, 75015 Paris, France.; Schulze Zur Wiesch J; Department of Internal Medicine, UMC Hamburg-Eppendorf, 20251 Hamburg, Germany.; Boelens JJ; Department of Hematology and Oncology, Princess Maxima Center, 3584 CS Utrecht, The Netherlands.; Stem Cell Transplant and Cellular Therapies, Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Martinez-Picado J; IrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Kuball JHE; Department of Hematology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Central Laboratory of Translational Immunology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Wensing AMJ; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.; Nijhuis M; Department of Medical Microbiology, University Medical Center Utrecht (UMCU), 3584 CX Utrecht, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

Carapito R; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France. carapito@unistra.fr.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France. carapito@unistra.fr.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France. carapito@unistra.fr.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan. carapito@unistra.fr.; Laboratoire d'Immunologie, Plateau Technique de Biologie, Pôle de Biologie, Nouvel Hôpital Civil, Strasbourg, France. carapito@unistra.fr.; Aouadi I; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan.; Pichot A; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan.; Spinnhirny P; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan.; Morlon A; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; BIOMICA SAS, Strasbourg, France.; Kotova I; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; BIOMICA SAS, Strasbourg, France.; Macquin C; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan.; Rolli V; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan.; Cesbron A; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Etablissement Français du Sang (EFS) Centre-Pays de la Loire, Laboratoire HLA, Nantes, France.; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI), Paris, France.; Gagne K; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Etablissement Français du Sang (EFS) Centre-Pays de la Loire, Laboratoire HLA, Nantes, France.; INSERM 1232, CRCINA, Université Nantes-Angers, Nantes, France.; Oudshoorn M; Europdonor operated by Matchis Foundation, Leiden, The Netherlands.; Department of Immunohematology and Blood transfusion, LUMC, Leiden, The Netherlands.; van der Holt B; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Labalette M; Laboratoire d'Immunologie, CHRU de Lille, Lille, France.; LIRIC INSERM U995, Université Lille 2, Lille, France.; Spierings E; Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Picard C; CNRS, EFS-PACA, ADES UMR 7268, Aix-Marseille Université, Marseille, France.; Loiseau P; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Laboratoire Jean Dausset, INSERM UMR_S 1160, Hôpital Saint-Louis, Paris, France.; Tamouza R; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Laboratoire Jean Dausset, INSERM UMR_S 1160, Hôpital Saint-Louis, Paris, France.; Toubert A; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Laboratoire Jean Dausset, INSERM UMR_S 1160, Hôpital Saint-Louis, Paris, France.; Parissiadis A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Etablissement Français du Sang (EFS) Grand-Est, Laboratoire HLA, Strasbourg, France.; Dubois V; Etablissement Français du Sang (EFS) Rhône-Alpes, Laboratoire HLA, Lyon, France.; Paillard C; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Service d'Hématologie et d'Oncologie pédiatrique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Maumy-Bertrand M; Institut de Recherche Mathématique Avancée, CNRS UMR 7501, LabEx Institut de Recherche en Mathématiques, ses Interactions et Applications, Université de Strasbourg, Strasbourg, France.; Bertrand F; Institut de Recherche Mathématique Avancée, CNRS UMR 7501, LabEx Institut de Recherche en Mathématiques, ses Interactions et Applications, Université de Strasbourg, Strasbourg, France.; von dem Borne PA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Kuball JHE; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Michallet M; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Centre Hospitalier Lyon Sud, Hématologie 1G, Hospices Civils de Lyon, Pierre Bénite, Lyon, France.; Lioure B; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Service d'Hématologie Adulte, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Peffault de Latour R; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Service d'Hématologie - Greffe, Hôpital Saint-Louis, APHP, Paris, France.; Blaise D; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Institut Paoli Calmettes, Marseille, France.; Cornelissen JJ; Department of Hematology and ErasmusMC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Yakoub-Agha I; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; LIRIC INSERM U995, Université Lille 2, Lille, France.; Claas F; Department of Immunohematology and Blood transfusion, LUMC, Leiden, The Netherlands.; Moreau P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Service d'Hématologie Clinique, CHU Hôtel Dieu, Nantes, France.; Charron D; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Laboratoire Jean Dausset, INSERM UMR_S 1160, Hôpital Saint-Louis, Paris, France.; Mohty M; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Département d'Hématologie, Hôpital Saint Antoine, Paris, France.; Université Pierre & Marie Curie, Paris, France.; Centre de Recherche Saint-Antoine, INSERM UMR_S 938, Paris, France.; Morishima Y; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Japan.; Socié G; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Hôpital Edouard Herriot, CHU, Lyon, France.; Service d'Hématologie Adulte, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Bahram S; Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Plateforme GENOMAX, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France. siamak@unistra.fr.; Labex TRANSPLANTEX, Faculté de Médecine, Université de Strasbourg, Strasbourg, France. siamak@unistra.fr.; INSERM Franco-Japanese Nextgen HLA Laboratory, Strasbourg, France. siamak@unistra.fr.; INSERM Franco-Japanese Nextgen HLA Laboratory, Nagano, Japan. siamak@unistra.fr.; Laboratoire d'Immunologie, Plateau Technique de Biologie, Pôle de Biologie, Nouvel Hôpital Civil, Strasbourg, France. siamak@unistra.fr.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Timmerman LM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Hensen LCM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; van Eijs MJM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Meyaard L; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van der Vlist M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. mvlist2@umcutrecht.nl.; Oncode Institute, Utrecht, The Netherlands. mvlist2@umcutrecht.nl.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

van Eijs MJM; Department of Medical Oncology, University Medical Center Utrecht, KC.02.085.2, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands. m.j.m.vaneijs-2@umcutrecht.nl.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands. m.j.m.vaneijs-2@umcutrecht.nl.; Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, KC.02.085.2, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands.; van der Wees SA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Nierkens S; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; van Lindert ASR; Department of Pulmonology, University Medical Center Utrecht, Utrecht, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, KC.02.085.2, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands.; van Wijk F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Zeiser R; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Polverelli N; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Ram R; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Hashmi SK; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Chakraverty R; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Middeke JM; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Musso M; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Giebel S; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Uzay A; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Langmuir P; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Hollaender N; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Gowda M; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Stefanelli T; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Lee SJ; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Teshima T; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).; Locatelli F; From the Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg (R.Z.), and Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden (J.M.M.) - both in Germany; the Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia (N.P.), UOC di Oncoematologia e TMO, Dipartimento Oncologico 'la Maddalena,' Palermo (M.M.), and Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome (F.L.) - all in Italy; the BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (R.R.); the Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (S.K.H.); the Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates (S.K.H.); UCL Cancer Institute, Institute of Immunity and Transplantation, London (R.C.); the Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland (S.G.); Acibadem University Hospital, Hematology Department, Istanbul, Turkey (A.U.); Incyte, Wilmington, DE (P.L.); Novartis Pharma, Basel, Switzerland (N.H., T.S.); Novartis Pharmaceuticals, East Hanover, NJ (M.G.); the Fred Hutchinson Cancer Research Center, Seattle (S.J.L.); and the Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan (T.T.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE